Understanding and controlling how cancer cells transition between different states remains a critical challenge in tumor ...
Figure 1: Immunomodulatory effects of simulated MSCs. MSCs utilize different molecular mechanisms to suppress (in most cases) or activate immune cells. Orange arrows: inhibition; Green arrows: ...
For most types of cancer, the primary tumor is not the cause of death, but metastasis, the dissemination of cancer cells throughout the body. Metastatic progression is a complex cascade of steps, and ...
Not all cancer metastases have the same destructive effect. Researchers demonstrate different mechanisms in experiments. A recent paper in "Cell Reports", co-led by Dr. Christina Scheel from the Skin ...
Novel prognostic staging system for patients with de novo metastatic breast cancer: A real-world experience. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does ...
Glioblastoma multiforme (GBM) stands as a formidable adversary in oncology, characterized by its molecular complexity and relentless progression. Despite advancements, the high degree of tumor ...
CAMBRIDGE, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics (Nasdaq: ERNA) today announced it will investigate the ability of its lead iMSC-based cell therapy (ERNA-101) to induce and ...
Understanding in depth how tumors evolve to become malignant is the objective of a study recently published in the journal Nature Cancer. The findings demonstrate that within each tumor, groups of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results